Bei Lin

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 14

Top Topics

Candida Albicans

Endometrial Cancer

Long Noncoding Rna

Top Venues

Cancer cell international

Journal of cellular and molecular medicine

Journal of experimental & clinical cancer research : CR

Oxidative medicine and cellular longevity

This page only lists publications with an associated author ORCID identifier.

Publications

Qiu-Lin Ye, Yue Qi, Juan-Juan Liu, Yue-Xin Hu, Yuan Lv, Bei Lin
First case of endometrial cancer after yolk sac tumor in a patient with Li-Fraumeni syndrome. BMC women's health 23 (1) (2023)
Xiaocui Zhang, Meige Sun, Yisheng Jiao, Bei Lin, Qing Yang
PHGDH Inhibitor CBR-5884 Inhibits Epithelial Ovarian Cancer Progression via ROS/Wnt/ β -Catenin Pathway and Plays a Synergistic Role with PARP Inhibitor Olaparib. Oxidative medicine and cellular longevity 2022 (2022)
Yuexin Hu, Mingjun Zheng, Dandan Zhang, Rui Gou, Ouxuan Liu, Shuang Wang, Bei Lin
Identification of the prognostic value of a 2-gene signature of the WNT gene family in UCEC using bioinformatics and real-world data. Cancer cell international 21 (1) (2021)
Xiao Li, Caixia Wang, Shuang Wang, Yuexin Hu, Shan Jin, Ouxuan Liu, Rui Gou, Xin Nie, Juanjuan Liu, Bei Lin
YWHAE as an HE4 interacting protein can influence the malignant behaviour of ovarian cancer by regulating the PI3K/AKT and MAPK pathways. Cancer cell international 21 (1) (2021)
Lingling Gao, Xin Nie, Rui Gou, Yuexin Hu, Hui Dong, Xiao Li, Bei Lin
Exosomal ANXA2 derived from ovarian cancer cells regulates epithelial-mesenchymal plasticity of human peritoneal mesothelial cells. Journal of cellular and molecular medicine 25 (23) (2021)
Mingjun Zheng, Yuexin Hu, Rui Gou, Ouxuan Liu, Xin Nie, Xiao Li, Qing Liu, Yingying Hao, Juanjuan Liu, Bei Lin
Identification of immune-enhanced molecular subtype associated with BRCA1 mutations, immune checkpoints and clinical outcome in ovarian carcinoma. Journal of cellular and molecular medicine 24 (5) (2020)
Lingling Gao, Xiao Li, Qian Guo, Xin Nie, Yingying Hao, Qing Liu, Juanjuan Liu, Liancheng Zhu, Limei Yan, Bei Lin
Identification of PKP 2/3 as potential biomarkers of ovarian cancer based on bioinformatics and experiments. Cancer cell international 20 (2020)
Shuang Wang, Caixia Wang, Xiao Li, Yuexin Hu, Rui Gou, Qian Guo, Xin Nie, Juanjuan Liu, Liancheng Zhu, Bei Lin
Down-regulation of TRIB3 inhibits the progression of ovarian cancer via MEK/ERK signaling pathway. Cancer cell international 20 (2020)
Shuang Wang, Caixia Wang, Yuexin Hu, Xiao Li, Shan Jin, Ouxuan Liu, Rui Gou, Yuan Zhuang, Qian Guo, Xin Nie, Liancheng Zhu, Juanjuan Liu, Bei Lin
ZNF703 promotes tumor progression in ovarian cancer by interacting with HE4 and epigenetically regulating PEA15. Journal of experimental & clinical cancer research : CR 39 (1) (2020)
Lingling Gao, Xin Nie, Wenchao Zhang, Rui Gou, Yuexin Hu, Yue Qi, Xiao Li, Qing Liu, Juanjuan Liu, Bei Lin
Identification of long noncoding RNA RP11-89K21.1 and RP11-357H14.17 as prognostic signature of endometrial carcinoma via integrated bioinformatics analysis. Cancer cell international 20 (2020)
Caixia Wang, Mingjun Zheng, Shuang Wang, Xin Nie, Qian Guo, Lingling Gao, Xiao Li, Yue Qi, Juanjuan Liu, Bei Lin
Whole Genome Analysis and Prognostic Model Construction Based on Alternative Splicing Events in Endometrial Cancer. BioMed research international 2019 (2019)
Jing Wang, Lu Deng, Huiyu Zhuang, Juanjuan Liu, Dawo Liu, Xiao Li, Shan Jin, Liancheng Zhu, Huimin Wang, Bei Lin
Interaction of HE4 and ANXA2 exists in various malignant cells-HE4-ANXA2-MMP2 protein complex promotes cell migration. Cancer cell international 19 (2019)
Ming-Jun Zheng, Xiao Li, Yue-Xin Hu, Hui Dong, Rui Gou, Xin Nie, Qing Liu, Hao Ying-Ying, Juan-Juan Liu, Bei Lin
Identification of molecular marker associated with ovarian cancer prognosis using bioinformatics analysis and experiments. Journal of cellular physiology 234 (7) (2019)
Jing Wang, Mingjun Zheng, Liancheng Zhu, Lu Deng, Xiao Li, Linging Gao, Caixia Wang, Huimin Wang, Juanjuan Liu, Bei Lin
Low BCL9 expression inhibited ovarian epithelial malignant tumor progression by decreasing proliferation, migration, and increasing apoptosis to cancer cells. Cancer cell international 19 (2019)